{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Corcept Therapeutics Incorporated"},"Symbol":{"label":"Symbol","value":"CORT"},"Address":{"label":"Address","value":"149 COMMONWEALTH DRIVE, MENLO PARK, California, 94025, United States"},"Phone":{"label":"Phone","value":"+1 650 327-3270"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol."},"CompanyUrl":{"label":"Company Url","value":"https://www.corcept.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Hazel Hunt","title":"Chief Scientific Officer"},{"name":"Joseph Douglas Lyon","title":"Chief Technology & Accounting Officer"},{"name":"Joseph K. Belanoff","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}